Pradaxa Lawsuits Filed for Internal Bleeding and Heart Attacks - Attorneys Handling Pradaxa Lawsuits Offer No-Cost, No-Obligation Pradaxa Case Review
Pradaxa (dabigatran etexilate mesylate), an anti-coagulant drug, has been found to cause serious and even fatal bleeding incidents. Pradaxa is widely prescribed to reduce the risk of stroke in patients with atrial fibrillation. Atrial fibrillation (AFib) is the most commonly diagnosed heart arrhythmia; over 2.6 million Americans are affected by this life-threatening condition. Pradaxa, a direct thrombin inhibiting drug, prevents stroke by reducing the body’s ability to form blood clots. A 2011 FDA Safety Communication stated that Pradaxa may be more likely to cause life threatening bleeding than other drugs used for this purpose. People who have lost a family member to fatal Pradaxa bleeding are working with Pradaxa internal bleeding lawyers in order to seek compensation for medical bills and the pain and suffering associated with their loss.
This website offers comprehensive information about Pradaxa heart attack and internal bleeding risks and Pradaxa lawsuits, including why Pradaxa is prescribed to people with irregular heartbeat, what makes Pradaxa dangerous, where to find information about the Pradaxa internal bleeding FDA warning, what you might expect from a Pradaxa heart attack lawsuit or Pradaxa internal bleeding lawsuit, and how to contact a Pradaxa lawyer.